Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Howell

Showing results (771-780 of 849) with videos related to

Pageof 85
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2022
Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE TrialEileen P Scully, Evgenia Aga, Athe Tsibris, et al.
International Journal of Pharmaceutics|March 11, 2014
An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agentsStephanie E Barrett, Marc T Abrams, Rob Burke, et al.
JAMA|February 19, 2019
Effect of a Nurse-Led Preventive Psychological Intervention on Symptoms of Posttraumatic Stress Disorder Among Critically Ill Patients: A Randomized Clinical TrialDorothy M Wade, Paul R Mouncey, Alvin Richards-Belle, et al.
ESMO Open|September 6, 2024
Capivasertib and fulvestrant for patients with hormone receptor-positive advanced breast cancer: characterization, time course, and management of frequent adverse events from the phase III CAPItello-291 studyH S Rugo, M Oliveira, S J Howell, et al.
Genome Medicine|June 14, 2022
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy womenThomas E Bartlett, Iona Evans, Allison Jones, et al.
AIDS (London, England)|September 29, 2021
Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversalJames H McMahon, Vanessa A Evans, Jillian S Y Lau, et al.
Bioengineering & Translational Medicine|September 11, 2023
A high-throughput microfluidic mechanoporation platform to enable intracellular delivery of cyclic peptides in cell-based assaysStephen H Kasper, Stephanie Otten, Brian Squadroni, et al.
Journal of Personalized Medicine|February 25, 2022
Preliminary Acceptability of a Home-Based Peripheral Blood Collection Device for Viral Load Testing in the Context of Analytical Treatment Interruptions in HIV Cure Trials: Results from a Nationwide Survey in the United StatesKarine Dubé, Shadi Eskaf, Elizabeth Hastie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2021
Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral TherapyEmmanouil Papasavvas, Livio Azzoni, Brian N Ross, et al.
The Journal of Clinical Investigation|March 1, 2022
Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapyJustin Harper, Susan P Ribeiro, Chi Ngai Chan, et al.
Pageof 85

Showing results (771-780 of 849) with videos related to

Sort By:
Pageof 85
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2022
Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE TrialEileen P Scully, Evgenia Aga, Athe Tsibris, et al.
International Journal of Pharmaceutics|March 11, 2014
An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agentsStephanie E Barrett, Marc T Abrams, Rob Burke, et al.
JAMA|February 19, 2019
Effect of a Nurse-Led Preventive Psychological Intervention on Symptoms of Posttraumatic Stress Disorder Among Critically Ill Patients: A Randomized Clinical TrialDorothy M Wade, Paul R Mouncey, Alvin Richards-Belle, et al.
ESMO Open|September 6, 2024
Capivasertib and fulvestrant for patients with hormone receptor-positive advanced breast cancer: characterization, time course, and management of frequent adverse events from the phase III CAPItello-291 studyH S Rugo, M Oliveira, S J Howell, et al.
Genome Medicine|June 14, 2022
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy womenThomas E Bartlett, Iona Evans, Allison Jones, et al.
AIDS (London, England)|September 29, 2021
Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversalJames H McMahon, Vanessa A Evans, Jillian S Y Lau, et al.
Bioengineering & Translational Medicine|September 11, 2023
A high-throughput microfluidic mechanoporation platform to enable intracellular delivery of cyclic peptides in cell-based assaysStephen H Kasper, Stephanie Otten, Brian Squadroni, et al.
Journal of Personalized Medicine|February 25, 2022
Preliminary Acceptability of a Home-Based Peripheral Blood Collection Device for Viral Load Testing in the Context of Analytical Treatment Interruptions in HIV Cure Trials: Results from a Nationwide Survey in the United StatesKarine Dubé, Shadi Eskaf, Elizabeth Hastie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2021
Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral TherapyEmmanouil Papasavvas, Livio Azzoni, Brian N Ross, et al.
The Journal of Clinical Investigation|March 1, 2022
Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapyJustin Harper, Susan P Ribeiro, Chi Ngai Chan, et al.
Pageof 85